Morningstar gives Express Scripts A- credit rating

Express Scripts Holding Company said on Tuesday that it has received a credit rating of A- from Morningstar.

This rating indicates that Express Scripts Holding Company has a low default risk, as well as a three-star rating for its stock.

Several other analysts also have rated the company. Mizuho began coverage of Express Scripts shares last week, setting the company’s buy rating, as well as a $101 price as the stock target.

Zacks analysts recently announced a downgrade for Express Scripts shares, changing the company’s rating from "hold" to "sell."

Barclays analysts also gave an overweight rating, as well as a $102 share price target on July 2.

Analysts with Jefferies Group recently gave Express Scripts a $98 price target for its shares. The analysts also gave the company a rating of “buy” in a research note.

Deutsche Bank retained its “hold" rating on the company, setting a price target for shares at $95.

Altogether, one analyst gave Express Scripts stock a "sell" rating, 10 have given it a "buy" rating and nine have given it a "hold" rating. As of Tuesday, the stock with Express Scripts is on a "hold" rating, with $91.19 as an average target price.

Express Scripts began in 1986 in St. Louis as a result of a joint venture between a retail chain of more than 79 pharmacies (Medicare Glaser Inc.) and Sanus Corp. Health Systems.